This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2005-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Umeå, SE (2005)
- Ume{dot over (a)}, SE (2008)
Company Filing History:
Years Active: 2005-2008
Title: The Innovations of Anders Edlund
Introduction
Anders Edlund is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of molecular biology, particularly in the area of GABAB receptor research. With a total of 2 patents, his work has implications for understanding and modulating neurotransmitter systems.
Latest Patents
Anders Edlund's latest patents focus on nucleic acid molecules that constitute GABAB receptor 1 promoters P1a and/or P1b. These inventions include methods for screening compounds that act as modulators of GABAB receptor 1 transcription. The patents emphasize the use of these nucleic acid molecules in research and therapeutic applications.
Career Highlights
Anders Edlund is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to engage in cutting-edge research and development in the pharmaceutical industry. His contributions have been instrumental in advancing the understanding of GABAB receptors.
Collaborations
Anders has collaborated with notable colleagues such as Jonas Ekstrand and Thore Johansson. These collaborations have enriched his research and expanded the impact of his inventions in the scientific community.
Conclusion
Anders Edlund's innovative work in the field of molecular biology highlights the importance of research in understanding complex biological systems. His patents and collaborations reflect a commitment to advancing science and improving therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile